Lifespan Vision Ventures Leads Remedium Bio's Series A Financing
- Written by PR Newswire
![]() |
Investment supports advancement of Remedium's durable protein therapeutics platform toward first-in-human clinical development.
NORWALK, Conn., Aug. 10, 2026 /PRNewswire/ -- Lifespan Vision Ventures today announced that it is leading Remedium Bio, Inc.'s ("Remedium") $10 million Series A financing and has completed the round's initial closing, with...














